Cytarabine Supplier-Buyer Network — Trade Flow Analysis

Name: Cytarabine Supplier-Buyer Trade Network Dataset — 175+ Indian Exporters, 15+ Importers, 110+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cytarabine supplier network, Cytarabine buyers, pharmaceutical export India, Cytarabine trade data

TransData Nexus

Cytarabine

India Pharmaceutical Trade Intelligence

$10.7M175 Suppliers110 CountriesHS 30049049

ExportsIndia → NETHERLANDS13.5%India → BRAZIL12.5%

ImportsAUSTRALIA → India$4.5M BULGARIA → India$34.8K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ALLOGA FRANCE

Who Supplies Cytarabine? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Cytarabine exporter from India, with a market share of 17.2% and a total export value of $1.8M across 693 shipments. Their average shipment value of $2.7K is below the market average of $5.9K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $502.1K across 188 shipments (27.1% of this supplier's total exports)

• ACCORD FARMACUTICA LIMITEDA — $460.3K across 172 shipments (24.9% of this supplier's total exports)

• ALLOGA FRANCE — $345.8K across 130 shipments (18.7% of this supplier's total exports)

• ACCORD FARMACUTICA LIMITEDA — $284.8K across 107 shipments (15.4% of this supplier's total exports)

• ACCORD FARMACUTICA LIMITEDA — $256.8K across 96 shipments (13.9% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (693 shipments) at a per-shipment value of $2.7K, indicating a broad distribution network with many smaller, regular orders.

2FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the second-largest Cytarabine exporter from India, with a market share of 7.9% and a total export value of $853.0K across 98 shipments. Their average shipment value of $8.7K is above the market average of $5.9K, suggesting premium or bulk contract pricing.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FRESENIUS KABI SOUTH AFRICA (PTY) L — $217.9K across 25 shipments (25.5% of this supplier's total exports)

• FRESENIUS KABI (THAILAND) LTD., — $211.5K across 24 shipments (24.8% of this supplier's total exports)

• FRESENIUS KABI MALAYSIA SDN BHD — $174.4K across 20 shipments (20.4% of this supplier's total exports)

• FRESENIUS KABI SOUTH AFRICA (PTY) L — $134.7K across 15 shipments (15.8% of this supplier's total exports)

• FRESENIUS KABI SOUTH AFRICA (PTY) L — $114.6K across 13 shipments (13.4% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $8.7K is 48% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.

3ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED

ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED is the third-largest Cytarabine exporter from India, with a market share of 4.6% and a total export value of $498.8K across 11 shipments. Their average shipment value of $45.3K is above the market average of $5.9K, suggesting premium or bulk contract pricing.

ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED serves 2 named buyers in our database. PFIZER SERVICE COMPANY BV is the dominant customer, accounting for 50.6% of this supplier's tracked business. Top customers include:

• PFIZER SERVICE COMPANY BV — $252.6K across 6 shipments (50.6% of this supplier's total exports)

• XXIZEXXSERXXCE XXMPAXX BV — $246.2K across 5 shipments (49.4% of this supplier's total exports)

Key Insight: ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED's per-shipment value of $45.3K is 670% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.

4NAPROD LIFE SCIENCES PRIVATE LIMITED

NAPROD LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Cytarabine exporter from India, with a market share of 4.6% and a total export value of $490.8K across 52 shipments. Their average shipment value of $9.4K is above the market average of $5.9K, suggesting premium or bulk contract pricing.

NAPROD LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. MULTICARE PHARMACEUTICALS PHILIPPIN is the dominant customer, accounting for 55.6% of this supplier's tracked business. Top customers include:

• MULTICARE PHARMACEUTICALS PHILIPPIN — $272.7K across 29 shipments (55.6% of this supplier's total exports)

• MULTICARE PHARMACEUTICALS PHILIPPIN — $72.2K across 8 shipments (14.7% of this supplier's total exports)

• SEVEN PHARMA S A C — $68.8K across 7 shipments (14.0% of this supplier's total exports)

• AL PHARMA S A S DESC — $61.6K across 7 shipments (12.5% of this supplier's total exports)

• MULTICARE PHARMACEUTICALS PHILIPPIN — $15.5K across 2 shipments (3.2% of this supplier's total exports)

Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $9.4K is 60% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.

5RUS MED EXPORTS PVT. LTD.

RUS MED EXPORTS PVT. LTD. is the fifth-largest Cytarabine exporter from India, with a market share of 1.9% and a total export value of $202.5K across 16 shipments. Their average shipment value of $12.7K is above the market average of $5.9K, suggesting premium or bulk contract pricing.

RUS MED EXPORTS PVT. LTD. serves 2 named buyers in our database. M/S MANAS MED is the dominant customer, accounting for 95.4% of this supplier's tracked business. Top customers include:

• M/S MANAS MED — $193.2K across 15 shipments (95.4% of this supplier's total exports)

• M/S.MANASH MED — $9.3K across 1 shipments (4.6% of this supplier's total exports)

Key Insight: RUS MED EXPORTS PVT. LTD.'s per-shipment value of $12.7K is 115% above the market average of $5.9K, consistent with large-order contracts or value-added formulations.

6CELON LABORATORIES PRIVATE LIMITED

CELON LABORATORIES PRIVATE LIMITED is the fifth-largest Cytarabine exporter from India, with a market share of 1.1% and a total export value of $113.4K across 44 shipments. Their average shipment value of $2.6K is below the market average of $5.9K, reflecting a high-volume, competitive pricing strategy.

CELON LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SEVEN PHARMA EL SALV — $42.7K across 17 shipments (37.7% of this supplier's total exports)

• SEVEN PHARMA S A C — $26.9K across 10 shipments (23.7% of this supplier's total exports)

• I.E MEDICA INC — $16.0K across 6 shipments (14.1% of this supplier's total exports)

• SEVEN PHARMA DEL ECU — $14.0K across 5 shipments (12.3% of this supplier's total exports)

• I.E MEDICA INC — $13.8K across 5 shipments (12.2% of this supplier's total exports)

Key Insight: CELON LABORATORIES PRIVATE LIMITED operates with high shipment frequency (44 shipments) at a per-shipment value of $2.6K, indicating a broad distribution network with many smaller, regular orders.

1Netherlands

Netherlands ranks as the first-largest destination for Cytarabine imports from India, with a total trade value of $1.4M across 78 shipments — representing a 13.5% share of all Cytarabine exports. The average shipment value of $18.5K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cytarabine importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 36.7% ($530.3K) of this market's total imports.

• ALLOGA FRANCE — $530.3K (36.7% of Netherlands's total)

• BROCACEF NL : HUB — $385.2K (26.6% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $18.5K (215% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Cytarabine imports from India.

Primary Market

Secondary Market

2Brazil

Brazil ranks as the second-largest destination for Cytarabine imports from India, with a total trade value of $1.3M across 29 shipments — representing a 12.5% share of all Cytarabine exports. The average shipment value of $46.2K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Cytarabine importers in Brazil: ACCORD FARMACUTICA LTDA is the largest buyer, accounting for 34.3% ($460.3K) of this market's total imports.

• ACCORD FARMACUTICA LTDA — $460.3K (34.3% of Brazil's total)

• ACCORD FARMACUTICA LTDA. — $334.3K (24.9% of Brazil's total)

• ACCORD FARMACUTICA LIMITEDA — $256.8K (19.2% of Brazil's total)

Key Insight: Brazil's per-shipment average of $46.2K (685% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Cytarabine imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Cytarabine imports from India, with a total trade value of $542.4K across 25 shipments — representing a 5.0% share of all Cytarabine exports. The average shipment value of $21.7K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cytarabine importers in United Kingdom: ACCORD UK is the largest buyer, accounting for 81.4% ($441.7K) of this market's total imports.

• ACCORD UK — $441.7K (81.4% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $21.7K (268% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Cytarabine imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Cytarabine imports from India, with a total trade value of $517.7K across 0 shipments — representing a 4.8% share of all Cytarabine exports. The average shipment value of $517.7K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations.

Key Insight: Australia's per-shipment average of $517.7K (8694% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Cytarabine imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Cytarabine imports from India, with a total trade value of $489.1K across 6 shipments — representing a 4.6% share of all Cytarabine exports. The average shipment value of $81.5K is above the global average of $5.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cytarabine importers in South Africa: FRESENIUS KABI SOUTH AFRICA PTY LT is the largest buyer, accounting for 44.6% ($217.9K) of this market's total imports.

• FRESENIUS KABI SOUTH AFRICA PTY LT — $217.9K (44.6% of South Africa's total)

• FRESENIUS KABI SOUTH AFRICA (PTY) L — $134.7K (27.5% of South Africa's total)

Key Insight: South Africa's per-shipment average of $81.5K (1285% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Cytarabine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cytarabine.
2.Flow Mapping: 175 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,825 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 110 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,825 Verified Shipments

175 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cytarabine

Cytarabine

Who Supplies Cytarabine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cytarabine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cytarabine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2FRESENIUS KABI ONCOLOGY LIMITED

3ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED

4NAPROD LIFE SCIENCES PRIVATE LIMITED

5RUS MED EXPORTS PVT. LTD.

6CELON LABORATORIES PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Cytarabine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cytarabine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

2Brazil

3United Kingdom

4Australia

5South Africa

People Also Ask — Cytarabine Supplier & Trade Network

Cytarabine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology